Skip to main content
. 2020 May 30;20:488. doi: 10.1186/s12885-020-06979-y

Table 2.

Univariable and multivariable analysis for not being included in cancer patient pathways among colorectal, lung, breast and prostate cancer patients diagnosed in 2015–2016 in Norway

Colorectal Lung Breast Prostate
Univariate Multivariate Univariate Multivariate Univariate Multivariate Univariate Multivariate
OR [95%CI]* OR [95%CI]* OR [95%CI]* OR [95%CI]* OR [95%CI]* OR [95%CI]* OR [95%CI]* OR [95%CI]*
Year of diagnosis
 2015 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00]
 2016 0.61 [0.55,0.69] 0.60 [0.54,0.68] 0.58 [0.51,0.66] 0.55 [0.47,0.63] 0.33 [0.27,0.41] 0.31 [0.25,0.39] 0.56 [0.51,0.61] 0.51 [0.47,0.56]
 p-value < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001
Age group
 18–49 2.34 [1.81,3.04] 2.23 [1.70,2.91] 1.06 [0.63,1.78] 1.18 [0.69,2.01] 0.75 [0.55,1.02] 0.77 [0.56,1.06] 0.82 [0.53,1.25] 0.75 [0.48,1.16]
 50–59 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00]
 60–69 0.92 [0.74,1.14] 0.89 [0.72,1.11] 1.02 [0.78,1.33] 1.00 [0.76,1.32] 0.91 [0.70,1.18] 0.88 [0.67,1.15] 0.89 [0.77,1.03] 0.94 [0.81,1.09]
 70–79 1.00 [0.82,1.23] 0.93 [0.75,1.16] 1.19 [0.92,1.54] 1.11 [0.85,1.45] 1.00 [0.74,1.35] 0.79 [0.57,1.10] 1.37 [1.19,1.59] 1.58 [1.35,1.85]
 80–89 1.32 [1.07,1.63] 1.15 [0.92,1.45] 2.63 [2.01,3.44] 2.21 [1.67,2.94] 1.13 [0.80,1.61] 0.74 [0.49,1.10] 4.46 [3.75,5.31] 5.59 [4.60,6.78]
 90+ 3.31 [2.48,4.41] 2.50 [1.83,3.40] 5.39 [3.40,8.55] 4.68 [2.87,7.63] 1.45 [0.84,2.52] 0.92 [0.50,1.68] 14.0 [8.8,22.3] 17.3[10.7,28.0]
 p-value < 0.001 < 0.001 < 0.001 < 0.001 0.138 0.509 < 0.001 < 0.001
Sex
 Female 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00]
 Male 0.87 [0.78,0.97] 0.93 [0.83,1.05] 0.91 [0.80,1.04] 0.86 [0.75,0.99] 1.00 [1.00,1.00] 1.00 [1.00,1.00]
 p-value 0.014 0.240 0.152 0.040
Stagea
 A 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00]
 B 0.58 [0.50,0.67] 0.57 [0.49,0.66] 1.34 [1.04,1.74] 1.41 [1.09,1.83] 1.01 [0.72,1.40] 1.02 [0.73,1.43] 0.52 [0.46,0.57] 0.44 [0.39,0.49]
 C 1.20 [1.03,1.41] 1.19 [1.01,1.40] 3.25 [2.59,4.08] 3.44 [2.72,4.35] 5.21 [3.77,7.20] 5.94 [4.20,8.40] 1.24 [1.04,1.47] 0.74 [0.61,0.89]
 D 1.41 [1.14,1.73] 1.22 [0.98,1.52] 4.28 [3.31,5.54] 4.08 [3.12,5.32] 3.33 [2.45,4.51] 3.36 [2.41,4.68] 0.86 [0.76,0.96] 0.69 [0.61,0.78]
 p-value < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001
Marital status
 Single 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00]
 Married 0.71 [0.64,0.79] 0.81 [0.72,0.92] 0.82 [0.72,0.94] 0.93 [0.81,1.08] 1.02 [0.84,1.23] 1.03 [0.83,1.28] 0.89 [0.81,0.97] 0.89 [0.80,0.98]
 p-value < 0.001 < 0.001 0.003 0.351 0.870 0.776 0.010 0.022
Education
 Low 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00]
 Intermediate 0.84 [0.74,0.95] 0.95 [0.83,1.09] 0.85 [0.74,0.98] 0.96 [0.83,1.12] 0.84 [0.66,1.06] 0.92 [0.72,1.18] 0.79 [0.71,0.88] 0.92 [0.82,1.04]
 High 0.85 [0.73,0.99] 0.98 [0.82,1.17] 0.71 [0.57,0.89] 0.88 [0.68,1.13] 0.75 [0.58,0.96] 0.97 [0.72,1.31] 0.81 [0.72,0.92] 1.03 [0.89,1.18]
 p-value 0.015 0.770 0.004 0.592 0.079 0.796 < 0.001 0.120
Income
 Low 1.29 [1.07,1.55] 1.24 [1.00,1.54] 1.97 [1.55,2.51] 1.52 [1.16,1.99] 1.72 [1.27,2.33] 1.42 [0.99,2.03] 1.72 [1.47,2.02] 1.05 [0.87,1.27]
 Intermediate 1.15 [1.00,1.32] 1.13 [0.97,1.33] 1.47 [1.21,1.81] 1.16 [0.93,1.45] 1.39 [1.13,1.72] 1.21 [0.94,1.54] 1.29 [1.18,1.42] 0.94 [0.84,1.05]
 High 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00]
 p-value 0.025 0.146 < 0.001 0.004 < 0.001 0.135 < 0.001 0.310
Regionb
 South-East 1.10 [1.04,1.16] 1.11 [1.05,1.17] 1.07 [1.01,1.14] 1.08 [1.01,1.15] 0.85 [0.78,0.93] 0.85 [0.78,0.93] 0.95 [0.91,0.98] 0.96 [0.92,1.00]
 West 0.93 [0.83,1.04] 0.93 [0.83,1.04] 0.99 [0.88,1.13] 1.01 [0.88,1.15] 1.12 [0.92,1.36] 1.09 [0.89,1.33] 1.41 [1.30,1.53] 1.39 [1.27,1.51]
 Mid 1.10 [0.97,1.25] 1.09 [0.95,1.25] 1.21 [1.02,1.42] 1.22 [1.02,1.45] 2.67 [2.22,3.21] 2.82 [2.32,3.43] 0.76 [0.68,0.85] 0.75 [0.67,0.84]
 North 0.62 [0.51,0.75] 0.59 [0.49,0.72] 0.55 [0.44,0.70] 0.52 [0.41,0.66] 0.48 [0.31,0.75] 0.48 [0.31,0.75] 1.02 [0.89,1.17] 1.04 [0.89,1.20]
 p-value < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001
Comorbidity
 No admissions 1.01 [0.75,1.36] 0.97 [0.71,1.32] 0.53 [0.26,1.06] 0.48 [0.23,0.97] 0.74 [0.58,0.96] 0.90 [0.69,1.17] 1.76 [1.55,2.00] 2.00 [1.75,2.29]
 0 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00]
 1–2 1.21 [1.06,1.39] 1.18 [1.02,1.36] 1.23 [1.07,1.41] 1.28 [1.10,1.49] 1.09 [0.79,1.51] 1.07 [0.75,1.51] 1.65 [1.47,1.85] 1.38 [1.22,1.56]
 3+ 1.83 [1.42,2.36] 1.67 [1.28,2.18] 1.95 [1.55,2.45] 1.90 [1.48,2.44] 1.94 [1.02,3.68] 1.09 [0.54,2.19] 3.24 [2.52,4.17] 2.31 [1.75,3.06]
 p-value < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001

aColorectal, lung and prostate: Localised (A), Regional (B), Metastasis (C), Unknown (D). Breast: Stage I-II (A), Stage III (B), Stage IV (C), Unknown (D)

bCompared with Norway (mean)

*Odds Ratio [95% c onfidence interval]